The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: A randomized, double-blind study with open-label extension

Hypertension Research

Volumn 40, Issue 1, 2017, Pages 51-60

  Higaki, Jitsuo ^a   Komuro, Issei ^b   Shiki, Kosuke ^c   Ugai, Hiroyuki ^c   Taniguchi, Atsushi ^c   Ikeda, Hiroshi ^c   Kuroki, Daisuke ^c   Nishimura, Seiichiro ^c   Ogihara, Toshio ^d  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^d MORINOMIYA UNIVERSITY OF MEDICAL SCIENCES   (Japan)

Author keywords

Amlodipine; Combination therapy; Hydrochlorothiazide; Telmisartan

Indexed keywords

AMLODIPINE; GAMMA GLUTAMYLTRANSFERASE; HYDROCHLOROTHIAZIDE; TELMISARTAN; URIC ACID; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; COUGHING; DERMATITIS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ECZEMA; ELECTROCARDIOGRAPHY; FEMALE; GASTROINTESTINAL DISEASE; GOUT; HEADACHE; HEART RATE; HUMAN; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; UPPER RESPIRATORY TRACT INFECTION; VASCULAR DISEASE; BLOOD PRESSURE; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DRUG EFFECTS; JAPAN; TREATMENT OUTCOME;

ADULT; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 85008423006     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2016.100     Document Type: Article

References (18)

1. Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Shimosawa T, Suzuki H, Tamura K, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S, Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014; 37: 253-390.
2. Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T, Wada K, Stickley A, Katanoda K, Mizoue T, Noda M, Iso H, Fujino Y, Sobue T, Tsugane S, Naghavi M, Ezzati M, Shibuya K. What has made the population of Japan healthy? Lancet 2011; 378: 1094-1105.
3. Fujiyoshi A, Ohkubo T, Miura K, Murakami Y, Nagasawa SY, Okamura T, Ueshima H, Observational Cohorts in Japan (EPOCH-JAPAN) Research Group. Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res 2012; 35: 947-953.
4. Kario K. Proposal of a new strategy for ambulatory blood pressure profile-based management of resistant hypertension in the era of renal denervation. Hypertens Res 2013; 36: 478-484.
5. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M, Kadota A, Okuda N, Kadowaki T, Nakamura Y, Okamura T. Cardiovascular disease and risk factors in Asia: a selected review. Circulation 2008; 118: 2702-2709.
6. Miura K. Comprehensive research business on strategies to prevent/treat cardiovascular disease/lifestyle-related diseases such as diabetes mellitus by a scientific grant/subsidy from the Ministry of Health, Labour and Welfare, 'Research on the start of follow-up of the subjects of the 2010 National Health and Nutrition Survey (NIPPON DATA2010) and continuation of NIPPON DATA80/90 follow-up', Comprehensive/project study reports in 2012. 2013 Ministry of Health, Labour and Welfare, Japan. (In Japanese).
7. Miura K, Nagai M, Ohkubo T. Epidemiology of hypertension in Japan. Circ J 2013; 77: 2226-2231.
8. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120: 713-719.
9. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010; 55: 399-407.
10. Shiga Y, Miura S, Mitsutake R, Norimatsu K, Nagata I, Arimura T, Shimizu T, Morii J, Kuwano T, Uehara Y, Inoue A, Shirotani T, Fujisawa K, Matsunaga E, Saku K. Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertension. J Renin Angiotensin Aldosterone Syst 2012; 13: 394-400.
11. Bays H, Zhu D, Schumacher H. Single-pill combination of telmisartan and hydrochlorothiazide: studies and pooled analyses of earlier hypertension treatment. High Blood Press Cardiovasc Prev 2014; 21: 119-126.
12. Webb AJ, Rothwell PM. Effect of dose and combination of antihypertensives on interindividual blood pressure variability: a systematic review. Stroke 2011; 42: 2860-2865.
13. Balraj MS, Faruqui AA. Efficacy and safety of triple drug fixed-dose combination of telmisartan, amlodipine and hydrochlorothiazide in the management of hypertension. Int J Res Med Sci 2015; 3: 1858-1862.
14. Maladkar M, Verma VK, Narsikar KA, Walinjkar RD, Patil WR, Saggu NJS, Kulkarni SP. Triple drug combination of telmisartan, amlodipine and hydrochlorothiazide in the treatment of essential hypertension. Open J Intern Med 2012; 2: 67-71.
15. Rakugi H, Tsuchihashi T, Shimada K, Numaguchi H, Nishida C, Yamaguchi H, Shirakawa M, Azuma K, Fujita KP. Add-on effect of hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension uncontrolled with losartan 50 mg and amlodipine 5 mg. Hypertens Res 2015; 38: 329-335.
16. Shiga Y, Miura S, Adachi S, Suematsu Y, Sugihara M, Iwata A, Yahiro E, Nishikawa H, Ogawa M, Saku K. Visit-to-visit variability and seasonal variation in blood pressure with single-pill fixed-dose combinations of angiotensin II receptor blocker/calcium channel blocker and angiotensin II receptor blocker/diuretic in hypertensive patients. J Clin Med Res 2015; 7: 802-806.
17. Machnicki G, Ong SH, Chen W, Wei ZJ, Kahler KH. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, health care utilization and costs. Curr Med Res Opin 2015; 23: 1-29.
18. Mohan JC, Jain R, Chamle V, Bhargava A. Short Term Safety and Tolerability of a Fixed Dose Combination of Olmesartan, Amlodipine and Hydrochlorothiazide. J Clin Diagn Res 2015; 9: OC10-OC13.